| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.0001 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.21 | 0.0004 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0005 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |